ID   Me4686
AC   CVCL_HE99
SY   4686
DR   Wikidata; Q54904972
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9973437;
RX   PubMed=25576923;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 6
//
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RA   Grazia G.;
RT   "Co-targeting of oncogenic and death receptors pathways in human
RT   melanoma: pre-clinical rationale for a pro-apoptotic and anti-angiogenic
RT   strategy.";
RL   Thesis PhD (2015); Universita degli studi di Milano; Milano; Italy.
//
RX   PubMed=9973437; DOI=10.4049/jimmunol.162.3.1739;
RA   Castelli C., Tarsini P., Mazzocchi A., Rini F., Rivoltini L.,
RA   Ravagnani F., Gallino F., Belli F., Parmiani G.;
RT   "Novel HLA-Cw8-restricted T cell epitopes derived from
RT   tyrosinase-related protein-2 and gp100 melanoma antigens.";
RL   J. Immunol. 162:1739-1748(1999).
//
RX   PubMed=25576923; DOI=10.18632/oncotarget.2995; PMCID=PMC4413617;
RA   Loria R., Bon G., Perotti V., Gallo E., Bersani I., Baldassari P.,
RA   Porru M., Leonetti C., Di Carlo S., Visca P., Brizzi M.F.,
RA   Anichini A., Mortarini R., Falcioni R.;
RT   "Sema6A and Mical1 control cell growth and survival of BRAFV600E human
RT   melanoma cells.";
RL   Oncotarget 6:2779-2793(2015).
//